The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
Europe’s anti-fraud office has launched an investigation into potential conflicts of interest at the EU’s drug approval agency.
An initiative that would require universities to post their researchers' industry ties online has faltered.
John Marburger became a lightning rod for criticism that the Bush administration had politicized climate change science and human embryonic stem cell research.
Pro-evolution bumper stickers and emblems are being removed from the cars of biologists in Florida.
A UK parliamentary panel says peer review is still valuable, but should be supplemented by open review processes, preprint servers, and online repositories.
An antibody that binds 16 different flu viruses offers hope for the long-sought universal vaccine.
A US judge dismisses a case against federal funding of human embryonic stem cell research.
A UK panel puts forth guidelines for research that use experimental animals harboring human cells and tissues.
The number of human embryonic stem cells approved for federal funding continues to grow.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
